Olmesartan: An overlooked cause for non-celiac sprue like enteropathy
Asian Journal of Pharmacy and Pharmacology · 2018
DOI: 10.31024/ajpp.2018.4.1.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Pharmacy and Pharmacology, 2018. Verfasst von Avnish Seth und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Objective: Chronic diarrhea is a frequently encountered clinical problem and is often challenging to diagnose.During the evaluation of chronic diarrhea, enteropathy is commonly found, but a specific etiology is not achieved.A druginduced enteropathy is overlooked quite often.Olmesartan is an angiotensin II receptor blocker (ARB), and Methods: is frequently prescribed by physicians in India.We present a case of 51 years female; who was managed for repeated episodes of sever diarrhea requiring repeated hospital admission for dehydration and acute kidney injury.Results and conclusion: On evaluation she was found to have enteropathy for which no cause could be elicited.She remained undiagnosed for months with persisted symptoms until an observation between her symptoms and olmesartan was observed.Her symptoms and enteropathy promptly resolved after discontinuing olmesartan.In this article a short review for the possible differential diagnosis for sprue like enteropathy will also be discussed.
Zitieren
APA
Seth, A., Gupta, V., & Jain, P. (2018). Olmesartan: An overlooked cause for non-celiac sprue like enteropathy. Asian Journal of Pharmacy and Pharmacology. https://doi.org/10.31024/ajpp.2018.4.1.15
Vancouver
Seth A, Gupta V, Jain P. Olmesartan: An overlooked cause for non-celiac sprue like enteropathy. Asian Journal of Pharmacy and Pharmacology. 2018. doi:10.31024/ajpp.2018.4.1.15
BibTeX
@article{Seth2018,
author = {Seth, Avnish and Gupta, Varun and Jain, Priti},
title = {Olmesartan: An overlooked cause for non-celiac sprue like enteropathy},
journal = {Asian Journal of Pharmacy and Pharmacology},
year = {2018},
doi = {10.31024/ajpp.2018.4.1.15}
}
EUVIMED